UPB Klow Blend ( BPC-157 10mg, TB-500 10mg, KPV 10mg and GHK-Cu 50mg)

UPB Klow Blend 80mg — Composition and Analytical Results

UPB Klow Blend combines BPC-157, TB-500, KPV, and GHK-Cu in a single lyophilized formulation supplied exclusively for laboratory research. Each vial is labeled with BPC-157 10mg, TB-500 10mg, KPV 10mg, and GHK-Cu 50mg, totaling 80mg.

The linked Kovera Labs Certificate of Analysis documents results for lot 11061-003. It includes blend purity, measured net content, component analysis, identification, and additional screening results.

What Does Klow Blend Contain?

• BPC-157: 10mg labeled quantity.
• TB-500: 10mg labeled quantity.
• KPV: 10mg labeled quantity.
• GHK-Cu: 50mg labeled quantity.

These four components are supplied together in one blend vial. The formulation name identifies the product and does not establish a biological outcome or suitability for a particular experiment.

Purity

Kovera Labs reports 99.743% average blend purity across three tested vials. The individual purity results are:

• Vial 1: 99.843%.
• Vial 2: 99.774%.
• Vial 3: 99.611%.

The chromatogram specifies RP-HPLC with a C18 column and DAD detection at 214nm. The report also records blend identification by LC-MS.

These percentages describe the tested blend samples. They are not separate purity measurements for each component, and they do not establish the quantity present.

Form

Lyophilized powder. The certificate records a teal cap and silver crimp for the submitted sample.

Research supplies, including Reconstitution Solution, are sold separately.

Quantity

Total labeled content: 80mg per vial. This consists of BPC-157 10mg, TB-500 10mg, KPV 10mg, and GHK-Cu 50mg.

The certificate reports 85.16mg average measured blend net content across three tested vials:

• Vial 1: 85.84mg.
• Vial 2: 86.02mg.
• Vial 3: 83.61mg.

The separate component-analysis section lists:

• BPC-157: 11.03mg measured content.
• TB-500: 11.28mg measured content.
• KPV: 10.18mg measured content.
• GHK-Cu: 53.35mg measured content.

The component figures total 85.84mg. They are separate from the reported 85.16mg average blend net content and should not be described as average component quantities.

Laboratory measurements apply to submitted samples. They do not change the labeled quantities or guarantee identical content in every vial.

Batch / Lot Number

11061-003

Match this number to the supplied vial before using the certificate in laboratory records. If the vial carries a different lot number, request its corresponding report.

Certificate of Analysis

• Testing laboratory: Kovera Labs.
• Client: Ultra Pure Bioscience.
• Product identified: Klow.
• Certification date: May 23, 2026.
• Report number: KVR-2026-6AF333.
• Access code: VEPHA09.
• Batch / lot: 11061-003.
• Labeled quantity: 80mg.
• Average blend purity: 99.743%.
• Average measured blend net content: 85.16mg.
• Blend identification by LC-MS: Klow.

Verify the Klow Blend Certificate of Analysis with Kovera Labs.

Additional Screening Results

The certificate also records the following findings:

• Endotoxin screen: PASS against the listed reference standard of ≤0.5 EU/mL.
• Microbial sterility screen: No Growth.
• Arsenic: Negative.
• Cadmium: Negative.
• Lead: Negative.
• Mercury: Negative.

These results reflect the samples and screening conditions documented by the laboratory. Negative screening results do not establish absolute absence, and the report does not guarantee sterility of every vial.

Handling & Storage

Follow the manufacturer’s product-specific instructions and your laboratory’s established handling procedures. Maintain accurate lot records and appropriate contamination controls.

The supplied certificate does not specify storage temperatures, shelf life, or conditions after preparation. Obtain these specifications from the supplier before laboratory use.

Research Use Only

UPB Klow Blend is supplied as a dry lyophilized powder exclusively for laboratory, analytical, and scientific research.

This product is not supplied as an FDA-approved medication. It is not intended for human or veterinary use, consumption, administration, diagnosis, prevention, or therapeutic application.

Frequently Asked Questions About Klow Blend

What is Klow Blend?

Klow Blend is a four-component research formulation containing BPC-157, TB-500, KPV, and GHK-Cu in one lyophilized product.

What does the 80mg quantity mean?

It is the total labeled content: BPC-157 10mg, TB-500 10mg, KPV 10mg, and GHK-Cu 50mg.

What purity is reported for this batch?

The certificate for lot 11061-003 reports 99.743% average blend purity across three tested vials. This is a blend result, not a separate percentage for each ingredient.

Why does the measured content differ from the label?

The label states the product’s nominal quantity. The certificate records measurements from submitted samples, including an average blend net content of 85.16mg. Those measurements do not guarantee identical content in every vial.

How does Klow Blend differ from Glow Blend?

Klow Blend includes KPV 10mg alongside BPC-157 10mg, TB-500 10mg, and GHK-Cu 50mg. The listed UPB Glow Blend contains the same labeled amounts of BPC-157, TB-500, and GHK-Cu without KPV.

How can I verify the Klow Blend COA?

Open the Kovera Labs verification link and review report KVR-2026-6AF333. Confirm that lot 11061-003 matches the vial. The certificate lists access code VEPHA09.

Is Reconstitution Solution included?

No. Reconstitution Solution is sold separately as a research supply.

Is Klow Blend intended for human or veterinary use?

No. It is supplied exclusively for laboratory, analytical, and scientific research.